|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| (11) | Patento numeris | 3236262 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17159039.1 |
| Europos patento paraiškos padavimo data | 2013-05-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261645253 P | 2012-05-10 | US | |
| 201361780252 P | 2013-03-13 | US |
| (72) |
PIERCEALL, William, US
CARDONE, Michael H., US
|
| (73) |
Eutropics Pharmaceuticals, Inc.,
767-C Concord Avenue, Cambridge, Massachusetts 02138,
US
|
| (54) | SURROGATE FUNCTIONAL DIAGNOSTICS TEST FOR CANCER |
| SURROGATE FUNCTIONAL DIAGNOSTICS TEST FOR CANCER |